Articles By Marcus Johnson

  1. California State Senator's New Bill Would Make Pharmaceutical Companies Pay For Drug Disposal 3/10/2014

    California state senator Hannah-Beth Jackson has introduced a new bill into the state legislature that would create a statewide drug disposal program. Under the bill, the program would be funded by pharmaceutical companies.

  2. Wyoming State Senate Votes To Loan Drug Company Cash 3/10/2014

    The state of Wyoming is going to lend $25 million to Lannett Co., which is a pharmaceutical company based in New Jersey. The company has plans to expand its Wyoming operations.

  3. Advocacy Group Lobbies FDA For Testosterone Warning Label 3/7/2014

    The consumer advocacy group Public Citizen is lobbying the FDA to add a “black box” warning to all testosterone products.

  4. Investors Buying Into Healthcare ETFs On The Back Of Drug Development 3/7/2014

    Investors are increasingly putting their money into ETFs that are focused on healthcare.

  5. Novartis And Roche Fined $251 Million By Italian Government 3/6/2014

    The Italian government fined drug industry giants Novartis and Roche $251 million dollars for their roles in a collusion plot to prevent Roche’s Avastin cancer drug from being used as a treatment for a disease affecting aging eyes.

  6. Indian Government Claims Counterfeit Drugs Have Invaded The Market 3/6/2014

    Counterfeit drugs have increasingly shown up in the Indian market, which is a serious problem for the Indian government.

  7. Takeda Pharmaceutical Acknowledges “Inappropriate” Drug Marketing 3/5/2014

    Takeda Pharmaceutical’s CEO, Tasuchika Hasegawa, has admitted that his company marketed blood pressure drug Blopress in a manner that didn’t align with Japanese law.

  8. Fake FDA Officials Demand Cash From Indian Pharmaceutical Companies 3/4/2014

    Indian regulators have released a document alerting domestic pharmaceutical companies and foreign pharmaceutical companies to a scam targeted at Indian drug companies.

  9. Endo Pharmaceuticals To Pay Connecticut In Court Resolution 3/4/2014

    The court case United States ex rel. Ryan v. Endo Pharmaceuticals has reached a settlement. The case started on allegations of wrongdoing on the behalf of Endo Pharmaceuticals.

  10. FDA Wants Changes To Drug Review System 2/26/2014

    The FDA is looking to make major changes to its non-prescription drug review system—a system which is more than 40 years old.